2017 Archive

Cancer Biology

Trio’s award awakens effects of sleep and sleep patterns

Valerie Crabtree, PhD

Find out how poor sleep hampers treatment of young children with cancer

Developmental Biology

Brain studies provide treatment clues in unexpected fields

Stanislav Zakharenko, MD, PhD

Research shows possible path to restoring critical regions of the brain involved with hearing loss by limiting a neuromodulator in the auditory thalamus.

Research

Supercharging T cells to fight cancer

Ben Youngblood, PhD

St. Jude researchers are combining therapeutic methods that induce epigenetic reprogramming with immune checkpoint blockade to enhance cancer treatments.

Outreach

Child Life course offers students first glimpse of the profession

Shawna Grissom

Twice a year, students get a first-hand look into what it means to specialize in child life.

Vaccinations

Skipping the flu vaccine? It’s not just about you

Richard Webby, PhD

The flu can be devastating for those most at-risk. It’s also highly contagious. You still think getting the flu is just about you?

Research

Understanding fatty acids as signaling molecules for virulence factor production

Charles Rock, PhD

Fatty acids are critical in destructive capacity of bacterial infections. Learn more.

Research

Apoptosis or necroptosis? The caspase-8 protein decides

Douglas R. Green, PhD

Programmed cell death can affect immune response to diseases such as cancer. Learn how caspase-8 chooses cell death and how that decision can be stopped.

Research

Secrets of aggressive, deadly cancers revealed in African yeast

Janet Partridge, PhD

Learn how a deadly pediatric cancer mutates a protein to cause a series of cellular malfunctions.

Profiles

Thirumala-Devi Kanneganti, PhD, honored for discoveries in immunology

Terrence L. Geiger, MD, PhD

Read how work by Dr. Thirumala-Devi Kanneganti, PhD, in immune response is being recognized by top professional organizations.

Pharmaceutical Sciences

Experimental cancer drug shows early promise against flu

Paul Thomas, PhD

The flu hijacks upper lung cells and turns them into flu factories. Read how an experimental cancer drug targets the flu’s fuel and shuts the factory down.